Our work demonstrates for the first time that in a cohort of patients with NSCLC, intra-tumor IRE1 splicing activity of XBP1 mRNA may impact tumor phenotypes and outcomes. This evidence concerns the gene ERN1 and non-small cell lung carcinoma.